• FDA Drug Ingredients and Development Process
  • US Drug Ingredients and Development Process

Keywords

  • Inactive Ingredients
  • UNII
  • FDA Registration
  • FDA Regulations
  • Inactive Ingredients
  • FDA Approval Calendar
  • FDA Inactive Ingredients
  • Unique Ingredient Identifier
  • Dissolution Methods
  • Dissolution Test Method
  • Tainted Products_x000D_
  • FDA Tainted Products_x000D_
  • Tainted Food Supplements

Drug Ingredients and Development Process Data Package

$159 / YEAR

This data package includes provides information on inactive ingredients present in FDA-approved drug products and information on dissolution methods presently recommended by the Division of Bioequivalence, Office of Generic Drugs of the Food and Drug Administration (FDA) for drug products that do not have a dissolution test method in the United States Pharmacopeia (USP). It also includes fraction of the potentially hazardous products with hidden ingredients marketed to consumers on the internet and in retail establishments.

Benefits
Full access to FDA drug dissolution methods; Full access to current FDA drugs inactive ingredients database.; Access to tainted products marketed as dietary supplements constituted from FDA alerts and warning.
Specification
Update Frequency: Quarterly
Data Complexity: Simple
Number of Datasets: 2
INCLUDED DATASETS
1. FDA Drug Dissolution Methods ($79)
2. Tainted Products Marketed as Dietary Supplements ($79)